SCHEMBL5963783

SCHEMBL5963783

CCNC1=C(c2ccc(F)cc2)S(=O)(=O)N(C)C12CCCCC2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.33
SLC6A3 Q01959 2/20 0.33
SLC6A2 P23975 2/20 0.33
KCNH2 Q12809 2/20 0.32
CACNA1I Q9P0X4 1/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
KMT2A Q03164 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
OPRM1 P35372 2/20 0.31
NR1D2 Q14995 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5963561 0.88 SLC6A2 (0.33) SLC6A4SLC6A3SLC6A2KCNH2LMNA
SCHEMBL6821070 0.70 APOL1 (0.36) MEN1ALDH1A1TSHRKMT2AOPRM1
SCHEMBL5963669 0.69 CHRNB2 (0.37) SLC6A4SLC6A3SLC6A2KCNH2GALR1
SCHEMBL5964213 0.69 HSD11B1 (0.33) SLC6A4SLC6A3SLC6A2LMNADRD2
SCHEMBL5001010 0.66 CACNA1G (0.38) ALDH1A1KMT2ADRD2SIGMAR1
SCHEMBL5963662 0.66 ADORA2B (0.35) SLC6A4SLC6A3SLC6A2MEN1ALDH1A1
SCHEMBL5963922 0.66 GALR1 (0.38) SLC6A4SLC6A3SLC6A2KCNH2MEN1
SCHEMBL5964017 0.65 GRIN1 (0.36) SLC6A4SLC6A3SLC6A2KCNH2ALDH1A1
SCHEMBL5004773 0.63 ALDH1A1 (0.36) SLC6A4SLC6A3MEN1ALDH1A1KMT2A
SCHEMBL6820982 0.62 KDM4E (0.36) SLC6A2ALDH1A1LMNADRD2P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125840-B2 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY (US) 2006-10-24 US disclosed
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues GHSR, GHRHR, SSTR4 SLC6A4 794/4885SLC6A3 981/4885SLC6A2 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.